Medical Management Of Placenta Accreta In A Primipara Following Vaginal Delivery

Read full text Summarise with VIRAT
Authors: Dr Anubha Singh Chandel
Cited by: 0
References: 4

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The incidence of placenta accreta, a potentially life-threatening obstetric condition has increased over the years. Women at greatest risk of placenta accreta are those who have myometrial damage caused by a previous cesarean delivery. Morbidly adherent placenta in the absence of risk factors is a rare entity in primigravida, and its conservative management becomes important in such patients to preserve future fertility. Here we present a case of placenta accreta in a primigravida with no known risk factors. The diagnosis was made following delivery where attempted, failed manual removal of placenta raised suspicion due lack of plane of separation between placenta and uterus. Diagnosis was confirmed by MRI and medical management with methotrexate was successfully done. Weekly follow-ups with clinical evaluation, serum beta Human Chorionic Gonadotropin, CBC, LFT and creatinine levels were done. Also two weekly imagings were done to look for placental morphological changes and vascularity

Fields of Study & Subjects

Maternal and fetal healthcare Uterine Myomas and Treatments Blood transfusion and management

Publication details

Journal / source
IOSR Journal of Dental and Medical Sciences
Volume
25
Issue
1
Pages
10–03
Publication date
1 January 2026
Language
EN